News and Announcements
Revolutionary 4Dx Locks Major Deal with Top US Hospital
- Published August 12, 2016 10:18AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
11th August 2016, Australian Anthill Bu Gerald Ainomugisha
Australian medtech start-up, 4Dx is a step closer to the integration of its visionary and breakthrough technology into everyday healthcare through its latest hardware sale to leading U.S. hospital, Cedars-Sinai Medical Center, a California nonprofit public benefit corporation.
Cedars-Sinai has received a grant award of US $600,000 from the United States National Institutes of Health for the purchase of 4Dx’s new preclinical lung scanner, making Cedars-Sinai the first institution scheduled to purchase this advanced instrument, which can help detect lung diseases in their early stages.
The new scanner addresses a dilemma of current antiquated technologies in measuring the impact of cystic fibrosis, asthma, COPD, emphysema and other disorders on the lung.
To view the full article, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
